Pharmacosmos launches Uniferon® in Russia

December 14, 2012

Danish company Pharmacosmos continues its expansion. Latest, the rapidly growing pig production industry in Russia has gained access to the Danes' Uniferon®, the industry-leading injectable iron supplement.

The industry-leading injectable iron supplement Uniferon® is under introduction to the Russian pig producing industry. Apart from providing Russian pig producers with access to state-of-the-art injectable iron, the launch represents an important step for the company behind Uniferon, Danish pharmaceutical company Pharmacosmos.

"We expect a huge interest in Uniferon as it represents a unique opportunity for the pig producers to profit from one of the safest and most efficient ways of administering iron to newborn pigs," said Mr. Zemtsov, CEO at Pharmacosmos' Russian partner Bioprom.

Moscow-based Bioprom is the country's largest supplier of a wide range of veterinary preparations for animal disease diagnostics, prevention and treatment.

Huge interest expected

"The Russian market with its massive growth and focus on productivity represents a large business opportunity for us and hence a significant step in our continuous expansion," said Jens Fabricius, Vice President, Marketing & Business Operations at Pharmacosmos A/S.

According to Dr Yury Kovalev, Director General of the National Union of Swine Breeders in Russia, at the latest EPP Congress the industrial pig production in Russia is set to continue its massive growth to an astounding 36.6 million pigs in 2015.

Quality, safety, efficacy

Uniferon is approved in Europe, Asia and North America, including FDA approval in the United States. Jens Fabricius underlines that the Russian pig producers now are assured an injectable iron that adheres to the highest standards of quality, safety and efficacy:

"Administering injectable iron to new born piglets and thus promoting optimal growth and general health as well as avoiding detrimental anaemia is today considered global best practice in the pig producing community," he said.

Pharmacosmos is acknowledged as a global leader in iron deficiency treatments for both humans and animals, and Uniferon, an all-natural injectable iron supplement for newborn piglets, is used by pig farmers throughout the world.

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.